Central Virginia Health Services has joined an antitrust lawsuit against four insulin and diabetes drug manufacturers over the companies’ denials of 340B pricing when covered entities use contract pharmacies.

Virginia Health Center Joins 340B-Related Antitrust Suit Against Insulin and Diabetes Drug Makers

A central Virginia community health center has joined an upstate New York health center’s antitrust lawsuit against four insulin and diabetes drug manufacturers over the companies’ denials of 340B pricing when covered entities use contract pharmacies.

Central Virginia Health Services’ (CVHS) status as a plaintiff emerged on Friday when it and the original plaintiff, Mosaic Health, filed an amended complaint in federal district court in Rochester, N.Y. Mosaic originally filed suit on July 30. Mosaic has 22 locations and CVHS has 18, all with 340B contract pharmacy arrangements.

A central Virginia community health center has joined an upstate New York health center’s antitrust lawsuit against four insulin and diabetes drug manufacturers over the companies’ denials of 340B pricing when covered entities use contract pharmacies.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

×

*Sign up for news summaries and alerts from 340B Report

Site Footer